FDA gives nod to BrainStorm for ALS trial after Phase III flop
BrainStorm Cell Therapeutics will be initiating a Phase IIIb confirmatory trial of its lead candidate NurOwn after discussions with the…
All articles by Abigail Beaney
Abigail Beaney
Abigail Beaney is a healthcare reporter for the Clinical Trials Arena. Coming from a journalistic background Abigail holds a BA (Hons) in Journalism from the University of Central Lancashire. Based in Manchester, Abigail has previously worked in local news and has interests in research into the treatment and prevention of cancer, heart disease and dementia.
-
-
Donanemab: FDA AdCom will put spotlight on tau enrolment and ARIA concerns
In May 2023, pharma giant Eli Lilly looked as if it was onto a winner after publishing positive topline data…
-
Amylyx considers scrapping ALS drug following Phase III flop
Amylyx Pharmaceuticals’s Phase III trial for amyotrophic lateral sclerosis (ALS) Relyvrio has failed to meet any of its endpoints. Following…
-
AD/PD 2024: AC Immune looks to second part of Phase II Parkinson’s vaccine trial
AC Immune is looking ahead to the second part of its Phase II Parkinson’s disease (PD) vaccine trial. The Swiss…
-
SCOPE: Changing protocol language and site actions are key to making trials inclusive
Changing the language used in trial protocols and continually conversing with sites are some ways by which trialists can make…
-
SCOPE: FDA facilitates AI and ML use for clinical trials and drug development
The US Food and Drug Administration (FDA) is focusing on how artificial intelligence (AI) can be used to support clinical…
-
Pharma and biotech concerned about the stability of large CROs, survey finds
Pharma and biotechs have shared concerns about working with large CROs, saying that the ‘one-stop shop’ model is no longer…
-
‘UK commercial clinical trials will double and double again’ – Lord James O’Shaughnessy
Lord James O’Shaughnessy, who created an in-depth report on the UK’s commercial clinical trial landscape after a significant decrease in…
-
Hope for the UK clinical trial landscape but it requires a lot of work
After a busy two-day discussion about what needs to be done to improve the UK’s contribution to clinical trials, there…
-
Cancer Research UK may go global as charity set to start trials in Europe
Cancer Research UK (CRUK) is soon to move away from its UK-centric model as it is in conversation with other…